»ý¹°Á¦Á¦ ÀÓ»ó½ÃÇè ¼öʱâ°ü ½ÃÀå : ¾÷°è µ¿Çâ°ú ¼¼°è ¿¹Ãø - »ý¹°Á¦Á¦ À¯Çüº°, »ç¾÷ ±Ô¸ðº°, Ä¡·á ¿µ¿ªº°, Áö¿ªº°
Biologics Contract Research Organization Market: Industry Trends and Global Forecasts - Distribution by Type of Biologic, Scale of Operation, Therapeutic Area, and Geography
»óǰÄÚµå : 1762533
¸®¼­Ä¡»ç : Roots Analysis
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 235 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,799 £Ü 6,650,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,999 £Ü 9,699,000
PDF (One-Location Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ Æ¯Á¤ »ç¾÷ ºÎ¹®¿¡ ¼ÓÇÑ ¸ðµç ºÐµéÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,599 £Ü 14,688,000
PDF (Department License) help
PDF º¸°í¼­¸¦ ºÎ¼­ ´ÜÀ§·Î 12¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,999 £Ü 24,943,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

»ý¹°Á¦Á¦ ÀÓ»ó½ÃÇè ¼öʱâ°ü ½ÃÀå : °³¿ä

¼¼°èÀÇ »ý¹°Á¦Á¦ ÀÓ»ó½ÃÇè ¼öʱâ°ü ½ÃÀå ±Ô¸ð´Â ¿ÃÇØ 215¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº ¿¹Ãø ±â°£ Áß 13%ÀÇ À¯¸®ÇÑ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­¿¡¼­´Â ½ÃÀå ±Ô¸ð¿Í ±âȸ ºÐ¼®À» ´ÙÀ½°ú °°Àº ¸Å°³ º¯¼ö·Î ±¸ºÐÇÕ´Ï´Ù.

»ý¹°Á¦Á¦ À¯Çü

»ç¾÷ ±Ô¸ð

Ä¡·á ¿µ¿ª

Áö¿ª

»ý¹°Á¦Á¦ ÀǾàǰ °³¹ß ¼öʱâ°ü ½ÃÀå : ¼ºÀå°ú µ¿Çâ

»ý¹°Á¦Á¦´Â Á¦¾à »ê¾÷¿¡¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â ºÐ¾ß Áß ÇϳªÀÔ´Ï´Ù. ÀÌ´Â È¿°úÀûÀÌ°í °³º°È­µÈ ¾à¸®ÇÐÀû °³ÀÔÀÇ Çʿ伺À¸·Î ÀÎÇØ ÀÌ ºÐ¾ßÀÇ ±â¼ú Çõ½ÅÀÌ ºü¸£°Ô ÁøÇàµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ±×·¯³ª »ý¹°Á¦Á¦ÀÇ °³¹ß°ú ÀÓ»ó½ÃÇèÀº ¸Å¿ì º¹ÀâÇÏ°í ºñ¿ëÀÌ ¸¹ÀÌ µå´Â °úÁ¤À¸·Î, Àü¹® Áö½Ä°ú ÷´Ü ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º ±â¼úÀÌ ¿ä±¸µË´Ï´Ù. ±× °á°ú, ¸¹Àº »ý¹°Á¦Á¦ ±â¾÷ÀÌ ½Å¾à°³¹ß ¹× Àӻ󿬱¸ ¾÷¹«ÀÇ ¾Æ¿ô¼Ò½ÌÀ» ¼±ÅÃÇϰí ÀÖ½À´Ï´Ù.

Biologics Contract Research Organization Market-IMG1

ÇöÀç ¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷Àº °³¹ß ÇÁ·Î¼¼½º¸¦ ¿ÜºÎ ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡ À§Å¹Çϰí, ÀڽŵéÀº ÀǾàǰ ¿¬±¸°³¹ßÀ» Ã¥ÀÓÁö´Â ºñÁî´Ï½º ¸ðµ¨À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ÜºÎ ¿¬±¸ ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ´Ù¾çÇÑ »ý¹°Á¦Á¦ °³¹ß À§Å¹±â°ü(CRO)À¸·Î¼­, ÀϹÝÀûÀ¸·Î °³¹ß ±â¾÷ÀÌ ´ã´çÇÏ´Â ÇÑ °¡Áö ÀÌ»óÀÇ Ã¥ÀÓÀ» ¸Ã°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ã¥ÀÓÀÇ ¿¹·Î´Â ÇÁ·ÎÅäÄÝ ¼³°è, ÀÓ»ó½ÃÇèÀÇ ¼±Åà ¶Ç´Â ¸ð´ÏÅ͸µ, º¸°í¼­ Æò°¡, ¹Ì±¹ FDA¿¡ Á¦ÃâÇÒ ¼­·ù ÀÛ¼º µîÀÌ ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ CRO°¡ Á¦°øÇÏ´Â ÁÖ¿ä ÀÌÁ¡À¸·Î´Â ½Ã°£ È¿À²¼º, ºñ¿ë È¿À²¼º, ±â¼ú Çõ½ÅÀÇ ¿­¼è, ǰÁú Çõ½Å µîÀÌ ÀÖ½À´Ï´Ù. ±× °á°ú, »ý¹°Á¦Á¦ °³¹ß ¾÷¹« À§Å¹±â°ü ½ÃÀåÀº »ý¹°Á¦Á¦ ½ºÆù¼­ Áõ°¡ÇÏ´Â ¿¬±¸°³¹ß ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ Á¡Â÷ È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

»ý¹°Á¦Á¦ °³¹ß À§Å¹±â°ü ½ÃÀå : ÁÖ¿ä ÀλçÀÌÆ®

ÀÌ º¸°í¼­¿¡¼­´Â »ý¹°Á¦Á¦ °³¹ß ¾÷¹« À§Å¹ ½ÃÀåÀÇ ÇöȲÀ» Á¶»çÇϰí, ÀáÀçÀûÀÎ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇß½À´Ï´Ù. ÁÖ¿ä Á¶»ç °á°ú´Â ´ÙÀ½°ú °°½À´Ï´Ù.

Biologics Contract Research Organization Market-IMG2
Biologics Contract Research Organization Market-IMG3

»ý¹°Á¦Á¦ ÀÓ»ó½ÃÇè ¼öʱâ°ü ½ÃÀåÀÇ Âü¿© ±â¾÷ ¿¹

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå °³¿ä

Á¦3Àå ¼­·Ð

Á¦3Àå ¼­·Ð

Á¦4Àå ¾Æ¿ô¼Ò½Ì °¡À̵å

Á¦5Àå ½ÃÀå ±¸µµ

Á¦6Àå ±â¾÷ °³¿ä

Á¦7Àå º¥Ä¡¸¶Å© ºÐ¼®

Á¦8Àå ÆÄÆ®³Ê½Ê°ú Çù¾÷

Á¦9Àå ÇÕº´°ú Àμö

Á¦10Àå ¸Å·Â°ú °æÀï·Â ¸ÅÆ®¸¯½º

Á¦11Àå ½ÃÀå ¿¹Ãø

Á¦12Àå SWOT ºÐ¼®

Á¦13Àå °á·Ð

Á¦14Àå Á¶»ç ±â·Ï

Á¦15Àå ºÎ·Ï I : Ç¥Çü½Ä µ¥ÀÌÅÍ

Á¦16Àå ºÎ·Ï II : ±â¾÷ ¹× Á¶Á÷ ¸®½ºÆ®

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

BIOLOGICS CONTRACT RESEARCH ORGANIZATION MARKET: OVERVIEW

As per Roots Analysis, the global biologics contract research organization market valued at USD 21.5 billion in the current year is anticipated to grow at a lucrative CAGR of 13% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Biologic

Scale of Operation

Therapeutic Area

Geography

BIOLOGICS CONTRACT RESEARCH ORGANIZATION MARKET: GROWTH AND TRENDS

Biologics represent one of the fastest growing segments of the pharmaceutical industry. This can

be attributed to the rapid pace of innovation in this field, driven by the need for effective and personalized pharmacological interventions. However, the development and clinical testing of biologics is a highly complex and costly process that demands specialized expertise and advanced bioprocessing technologies. As a result, many biopharmaceutical companies are choosing to outsource their drug discovery and clinical research operations.

Biologics Contract Research Organization Market - IMG1

Currently, biopharmaceutical companies are embracing a business model, wherein the development processes are outsourced to external service providers, whereas the company itself is responsible for the R&D of drugs. These external research service providers are various biopharma contract research organizations (CRO) that take on one or more responsibilities typically held by a developer. Examples of such responsibilities include protocol design, selection or monitoring of investigations, evaluation of reports, and preparation of documentation for submission to the US FDA. Key advantages offered by biopharma CRO include time efficiency, cost effectiveness, key to innovation, and quality innovation. Consequently, the biologics contract research organization market is anticipated to expand gradually to fulfil the growing R&D demands of biopharmaceutical sponsors.

BIOLOGICS CONTRACT RESEARCH ORGANIZATION MARKET: KEY INSIGHTS

The report delves into the current state of the biologics contract research organization market and identifies potential growth opportunities within industry. Some key findings from the report include:

Biologics Contract Research Organization Market - IMG2
Biologics Contract Research Organization Market - IMG3

Example Players in the Biologics Contract Research Organization Market

BIOLOGICS CONTRACT RESEARCH ORGANIZATION MARKET: RESEARCH COVERAGE

KEY QUESTIONS ANSWERED IN THIS REPORT

REASONS TO BUY THIS REPORT

ADDITIONAL BENEFITS

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3 Introduction

4. GUIDE TO OUTSOURCING

5. MARKET LANDSCAPE

6. COMPANY PROFILES

7. BENCHMARK ANALYSIS

8. PARTNERSHIPS AND COLLABORATIONS

9. MERGERS AND ACQUISITIONS

10. ATTRACTIVENESS COMPETATIVENESS MATRIX

11. MARKET FORECAST

12. SWOT ANALYSIS

13. CONCLUDING REMARKS

14. SURVEY TRANSCRIPTS

15. APPENDIX I: TABULATED DATA

16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â